| 1 |
Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitricoxide measurements: clinical application and interpretation[J]. Thorax, 2006, 61(9):817-827.
|
| 2 |
Bates CA, Silkoff PE. Exhaled nitric oxide in asthma：frombench to bedside[J]. J Allergy Clin Immunol, 2003, 111(2):256-262.
|
| 3 |
Lim KG, Mottram C. The use of fraction of exhaled nitricoxide in pulmonary practice[J]. Chest, 2008, 133(5):1232-1242.
|
| 4 |
Smith AD, Taylor DR. Is exhaled nitric oxide measurement a useful clinical test in asthma? [J]. Curr Opin Allergy Clin Immunol, 2005, 5(1):49-56.
|
| 5 |
Taylor DR. Nitric oxide as a clinical guide for asthma management[J]. J Allergy Clin Immunol, 2006, 117(2):259-262.
|
| 6 |
Hsu JY, Wang CY, Cheng YW, et al. Optimal value of fractional exhaled nitric oxide in inhaled corticosteroid treatment for patients with chronic cough of unknown cause[J]. J Chin Med Assoc, 2013, 76(1):15-19.
|
| 7 |
姚慧娟，张悦鸣，李志奎，等. 呼出气一氧化氮检测诊断支气管哮喘[J]. 国际呼吸杂志，2013, 33(7):508-512.
|
| 8 |
Cho HJ, Jung YH, Yang SI, et al. Reference values and determinants of fractional concentration of exhaled nitric oxide in healthy children[J]. Allergy Asthma Immunol Res, 2014, 6(2):169-174.
|
| 9 |
高瞻，杨旭，刘禹，等. 中性粒细胞性哮喘与稳定期COPD患者诱导痰中性粒细胞炎症程度比较的研究[J]. 免疫学杂志，2015, 31(5):408-412.
|
| 10 |
Chen XN, Zhu H, Meng QY, et al. Estrogen receptor-alpha and beta regulate the human orticotropin- releasing hormone gene through similar pathways[J]. Brain Res, 2008, 5(1):1-10.
|
| 11 |
张永明，林江涛，苏楠，等. 支气管哮喘患者气道炎症表型研究[J]. 中华结核和呼吸杂，2015, 38(5):348-351.
|
| 12 |
刘敏，许西琳，刘冬，等. 呼出气一氧化氮和外周血嗜酸性粒细胞百分率对支气管哮喘诊断和病情评估价值[J]. 中华实用诊断与治疗杂志，2017, 31(8):769-771.
|
| 13 |
陈华萍，马千里，张巧，等. 重庆地区健康成人诱导痰细胞计数及正常参考值的初步建立[J]. 第三军医大学学报，2011, 33(24):2611-2613.
|
| 14 |
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗、疗效判断标准及教育和管理方案)[J]. 中华结核和呼吸杂志，2003, 26(3):132-138.
|
| 15 |
祝筱姬，孟晓. 呼出气一氧化氮与支气管哮喘[J]. 临床肺科杂志，2014, (7):1318-1320.
|
| 16 |
Park SH, Im MJ, Eom SY, et al. Accuracy of maximal expiratory flow-volume curve curvilinearity and fractional exhaled nitric oxide for detection of children with atopic asthma[J]. Korean J Pediatr, 2017, 60(9):290-295.
|
| 17 |
Ludviksdottir D, Diamant Z, Alving K, et al. Clinieal aspeets of using exhaled NO in asthma diagnosis and management[J]. Clin Respir J, 2012, 6(4):193-207.
|
| 18 |
王珍，屠春林，王文韬，等. 慢性阻塞性肺疾病患者FeNO值测定的临床意义[J]. 临床肺科杂志，2017, 22(9):1644-1647.
|
| 19 |
Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2015[R/OL]. 2015-05-20[2016-05-05].
URL
|
| 20 |
中国医师协会呼吸医师分会. 无创气道炎症评估支气管哮喘的临床应用中国专家共识[J]. 中华结核和呼吸杂志，2015, 38(5):329-341.
|
| 21 |
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5):602-615.
|
| 22 |
Alcázar-Navarrete B, Romero-Palacios PJ, Ruiz-Sancho A, et al. Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes[J]. Nitric Oxide, 2016, 54:67-72.
|
| 23 |
黄金华，许浦生，黎教武，等. 支气管激发试验、FeNO及诱导痰ECP在哮喘中的相关性及FeNO、诱导痰ECP诊断价值[J]. 临床肺科杂志，2016, 21(7):1177-1181.
|
| 24 |
康闪闪，何晟，朱恬华，等. 慢性阻塞性肺疾病急性加重期治疗前后诱导痰细胞分类、血ECP变化的临床分析[J]. 中国临床医生，2014, 12(2):24-26.
|